Qualicaps Europe, S.A.U. receives cofunding awarded by the European Union through the Centre for the Development of Industrial Technology (CDTI) and the European Fund of Regional Development (FEDER - Fondo Europeo de Desarrollo Regional).

  • 03/27/2020
  • News
  • Capsules
  • Dosage Form
  • HPMC
  • Nutraceutical
  • Nutrition
Nutra'V Slow project awarded

 

In response to the growing interest of the market in the commercialization of nutritional supplements that require the partial release of the nutrients along the gut in order to reach their maximum efficacy, Qualicaps® has developed a new slow-release capsule for the administration of these products.. The novel capsule, Nutra’V Slow, is specifically designed to target moisture-sensitive and acid-labile ingredients by slowing down capsule rupture and release of contents. The elaboration process of Nutra’V Slow was designed to integrate seamlessly with the production processes of a company’s nutritional supplements.

An R&D project pursuing the elaboration of the novel slow-release cellulose capsule, together with the definition of a robust and reliable new ad-hoc experimental production process was addressed. The objectives taken into consideration were the following:
     • Design of a formulation based on cellulose so that the slow-release properties can be fulfilled.
     • Development of the stages of the experimental production process specifically designed for the novel slow-release capsule.
     • Development of all elements required for the implementation of the process.
     • Formal specification of the novel process.

The specific project, valued at over 400 thousands euros, has been conducted during the last year by Qualicaps Europe, S.A.U., located in Alcobendas (Madrid) and has been awarded cofunding by the European Union through the Centre for the Development of Industrial Technology (CDTI) and the European Regional Development Fund (FEDER - Fondo Europeo de Desarrollo Regional).